DEXCOM INC (DXCM)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NASDAQ
$89.88
+0.31%
Investingg Score
65.8 / 100
Hold
Business overview
- Gross margin of 60.1%
- Operating margin of 19.6%
These margins demonstrate a strong capacity to convert product sales into operating income within the medical instruments industry, though competitive pressures could introduce operational uncertainty.
Financial health
- Free cash flow margin of 23.1%
- Balance Sheet score of 56
These figures indicate healthy cash generation supporting financial stability, though the moderate balance sheet score highlights potential risks regarding debt obligations or capital structure.
- Gross Margin
- 60.1%
- Operating Margin
- 19.6%
- Current Ratio
- 1.9x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $1.1B
- Interest Coverage
- 64x
Valuation
- P/E ratio of 37.91
- Forward P/E of 26.06
- P/S ratio of 7.11
- Free cash flow yield of 3.1%
These valuation multiples suggest the stock commands a premium price relative to near-term earnings, implying high growth expectations are already priced in.
- P/E (TTM)
- 37.9x
- Forward P/E
- 26.1x
- Price / Sales
- 7.1x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 3.1%
Key risks
- Data unavailable for specific operational risks within the provided dataset.
- Potential overbought technical conditions as indicated by an RSI of 75.5.
- Valuation risk stemming from a high trailing P/E of 37.91.
Market cap $34.6B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze DXCM with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.